Urinary tract infection: Traditional pharmacologic therapies

Disease-a-Month

Volumn 49, Issue 2, 2003, Pages 111-128

  Nicolle, Lindsay E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEFACLOR; CEFALEXIN; CEFALOTIN; CEFCANEL; CEFDINIR; CEFIXIME; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; FOSFOMYCIN TROMETAMOL; GENTAMICIN; LEVOFLOXACIN; NALIDIXIC ACID; NITROFURANTOIN; PENICILLIN DERIVATIVE; PIPEMIDIC ACID; PIVMECILLINAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ANTIMICROBIAL THERAPY; BACTERIUM ISOLATE; CARDIOTOXICITY; CHOLECYSTITIS; CLINICAL PROTOCOL; CLINICAL TRIAL; CYSTITIS; DIABETES MELLITUS; DIARRHEA; DRUG BIOAVAILABILITY; DRUG CHOICE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG URINE LEVEL; DRUG UTILIZATION; EOSINOPHILIA; ESCHERICHIA COLI; GASTROINTESTINAL SYMPTOM; HOSPITALIZATION; HUMAN; LEUKOPENIA; LIVER TOXICITY; LUNG TOXICITY; NEPHROTOXICITY; NEUROTOXICITY; OTOTOXICITY; PATIENT SELECTION; PHARMACOKINETICS; PHOTOSENSITIVITY; POSTMENOPAUSE; PRACTICE GUIDELINE; PREGNANCY; RASH; RECURRENT INFECTION; REVIEW; RISK FACTOR; SHORT COURSE THERAPY; SYMPTOM; THROMBOCYTOSIS; URINARY TRACT INFECTION; VESTIBULAR DISORDER;

EID: 0037301166     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-5029(03)90004-6     Document Type: Review

References (42)

1. Brown PD. Antibiotic selection for urinary tract infection: new microbiologic considerations. Curr Infect Dis Rep 1999;1:384-388.
2. Nicolle LE. Pivmecillinam in the treatment of urinary tract infections. J Antimicrob Chemother 2000;46(suppl 1):35-39.
3. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001;135:41-50.
4. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997;11:551-581.
5. Gupta K, Sahm DF, Mayfield D, Stamm WE. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis 2001;33:89-94.
6. Warren JW, Abrutyn E, Hebel JR, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999;29:745-758.
7. Physicians Desk Reference, 55th edition. Montvale, NJ: Medical Economics Co., Inc.
8. Kahlmeter G. The ECO.SENS Project: a prospective, multinational, multicenter epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens. Interim Report. J Antimicrob Chemother 2000;46(suppl S1):15-22.
9. Hooton TM, Winter C, Tiu F, Stamm WE. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA 1995;273:41-45.
10. Johnson CC, Stamm WE. Urinary tract infection in women: diagnosis and treatment. Ann Intern Med 1989; 111:906-917.
11. Talan DA, Stamm WE, Hooton TM, et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA 2000;283:1583-1590.
12. TSN Database, MRL Pharmaceutical Services.
13. Wright SW, Wrenn KD, Haynes ML. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates. J Gen Intern Med 1999;14:606-609.
14. McCarty JM, Richard G, Huck W, et al. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women: Ciprofloxacin Urinary Tract Infection Group. Am J Med 1999;106:292-299.
15. Nicolle LE. A practical guide to the management of complicated urinary tract infection. Drugs 1997;53:583-592.
16. Iravani A, Klimberg I, Briefer C, et al. A trial comparing low-dose, short-course ciprofloxacin and standard 7-day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. J Antimicrob Chemother 1999;43(suppl A):67-75.
17. Nicolle LE, Hoepelman AI, Floor M, Verhoef J, Norgard K. Comparison of three days' therapy with cefcanel or amoxicillin for the treatment of acute uncomplicated urinary tract infection. Scand J Infect Dis 1993;25:631-637.
18. Leigh AP, Nemeth MA, Keyserling CH, et al. Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection. Clin Ther 2000;22:818-825.
19. Patel SS, Balfour JA, Bryson HM. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs 1997;53:637-656.
20. Minassian MA, Lewis DA, Chattopadhyay D, et al. A comparison between single dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women. Int J Antimicrob Agents 1998;10:9-47.
21. Stein GE. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. Clin Ther 1999;21:1864-1872.
22. Berg AO. Variations among family physicians' management strategies for lower urinary tract infection in women: a report from the Washington Family Physicians Collaborative Research Network. J Am Board Fam Pract 1991;4:327-330.
23. Hooton T. Practice guidelines for urinary tract infection in the era of managed care. Int J Antimicrob Agents 1999;11:241-245.
24. O'Connor PJ, Solberg LI, Christianson J, et al. Mechanism of action and impact of a cystitis clinical practice guideline on outcomes and costs of care in an HMO. Joint Comm J Qual Improv 1996;22:673-682.
25. Saint S, Scholes D, Fihn SD, Farrell RG, Stamm WE. The effectiveness of a clinical practice guideline for the management of presumed uncomplicated urinary tract infection in women. Am J Med 1999;106:636-641.
26. Schaeffer AJ, Stuppy BA. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections. J Urol 1999;161:207-211.
27. Gupta K, Hooton TM, Roberts PL, Stamm WE. Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann Intern Med 2001;135:9-16.
28. Cunningham FG, Lucas MJ. Urinary tract infections complicating pregnancy. Baillieres Clin Obstet Gynaecol 1994;8:353-373.
29. Krcmery S, Hromec J, Demesova D. Treatment of lower urinary tract infection in pregnancy. Int J Antimicrob Agents 2001;17:279-282.
30. North DH, Speed JE, Weiner WB, Morrison JC. Correlation of urinary tract infection with urinary screening at the first antepartum visit. J Miss State Med Assoc 1990;31:331-333.
31. Kass EH. Infectious disease and perinatal morbidity. Yale J Biol Med 1982;55:231-237.
32. Gilstrap LC III, Lucas MJ. Urinary tract infections in women. Curr Opin Obstet Gynecol 1990;2:643-648.
33. Grio R, Porpiglia M, Vetro E, et al. Asymptomatic bacteriuria in pregnancy: maternal and fetal complications. Panminerva Med 1994;36:198-200.
34. Graham JM, Oshiro BT, Blanco JD, Magee KP. Uterine contractions after antibiotic therapy for pyelonephritis in pregnancy. Am J Obstet Gynecol 1993;168:577-580.
35. Kiningham RB. Asymptomatic bacteriuria in pregnancy. Am Fam Physician 1993;47:1232-1238.
36. Gratacos E, Torres PJ, Vila J, et al. Screening and treatment of asymptomatic bacteriuria in pregnancy prevent pyelonephritis. J Infect Dis 1994;169:1390-1392.
37. Millar LK, Cox SM. Urinary tract infections complicating pregnancy. Infect Dis Clin North Am 1997;11:13-26.
38. Connolly A, Thorp JM Jr. Urinary tract infections in pregnancy. Urol Clin North Am 1999;26:779-787.
39. Patterson JE, Andriole VT. Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am 1997;11:735-750.
40. Delzell JE Jr, Lefevre ML. Urinary tract infections during pregnancy. Am Fam Physician 2000;61:713-721.
41. Pfau A, Sacks TG. Effective prophylaxis for recurrent urinary tract infections during pregnancy. Clin Infect Dis 1992;14:810-814.
42. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999;281:736-738.